XML 174 R56.htm IDEA: XBRL DOCUMENT v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 19, 2018
Reclassified from line of credit to Notes payable           $ 930,006  
Operating lease right-of-use asset           247,595  
Financing lease right-of-use asset           248,678  
Reclassified from accounts receivable           1,784,751  
Payable to actuarial expert         $ 408,665 147,776  
VAT net receivable and payable balance $ 322,576   $ 322,576   187,512 79,373  
Long-term liability 395,698   395,698   408,665 0  
Allowance for doubtful accounts     19,905,776   19,686,091 7,309,311  
Foreign accounts         1,047,738 831,793  
Cash on hand         48,590 15,690  
Sales to Medihelm         397,000    
Depreciation expense 89,694 $ 124,910 306,126 $ 237,479 353,043 70,109  
Amortization expense 196,183 $ 88,168 579,556 $ 138,438 239,841 33,085  
Goodwill 49,697   49,697   49,697 49,697 $ 49,697
ICC International Cannabis Corp [Member]              
Equity method investment aggregate cost 0   0   $ 0 $ 0  
Equity method investment shares acquired, shares         3,000,000 3,000,000  
Closing price         $ 0 $ 0  
National Bank of Greece [Member]              
Equity method investment aggregate cost 12,416   $ 12,416   $ 11,596 $ 6,681  
Equity method investment shares acquired, shares     16,666   16,666 16,666  
Closing price     $ 0.75   $ 0.70 $ 0.40  
Pancreta Bank [Member]              
Equity method investment aggregate cost $ 7,665   $ 7,665   $ 8,479 $ 8,200  
Greece [Member]              
Income tax rate     22.00%   22.00%    
United Kingdom Of England [Member]              
Income tax rate     25.00%   25.00%